Yuri Deigin — SPARQNOW

At-a-Glance

Co-Founder and CEO of Youthbio Therapeutics Inc., focusing on partial reprogramming gene therapies for Alzheimer's and other diseases.
CEO at Gero.
Fellow at Longevity Biotech Fellowship.
Biotech Fellow at Foresight Institute.
Member at Brainmind.

Biography

Yuri Deigin is a longevity biotech entrepreneur and drug developer. He is the Co-Founder and CEO of Youthbio Therapeutics Inc., where his work focuses on partial reprogramming gene therapies for Alzheimer's and other diseases.

Deigin also serves as CEO at Gero. His professional affiliations include being a Fellow at the Longevity Biotech Fellowship and a Biotech Fellow at the Foresight Institute. He is also a Member of Brainmind.